본문으로 건너뛰기
← 뒤로

99m Tc-PSMA Uptake in Neurofibroma.

1/5 보강
Clinical nuclear medicine 📖 저널 OA 3.9% 2021: 0/2 OA 2022: 1/12 OA 2023: 0/8 OA 2024: 0/22 OA 2025: 3/79 OA 2026: 5/104 OA 2021~2026 2025 Vol.50(10) p. e611-e613
Retraction 확인
출처

Samadi MH, Sahafi P, Elahifard H, Davoodi S, Askari E

📝 환자 설명용 한 줄

We present a 74-year-old man with a history of very high-risk prostate cancer (Gleason score: 5+4 in 11 of 14 cores) who was referred for initial staging with 99m Tc-HYNIC-PSMA.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Samadi MH, Sahafi P, et al. (2025). 99m Tc-PSMA Uptake in Neurofibroma.. Clinical nuclear medicine, 50(10), e611-e613. https://doi.org/10.1097/RLU.0000000000005797
MLA Samadi MH, et al.. "99m Tc-PSMA Uptake in Neurofibroma.." Clinical nuclear medicine, vol. 50, no. 10, 2025, pp. e611-e613.
PMID 40029825 ↗

Abstract

We present a 74-year-old man with a history of very high-risk prostate cancer (Gleason score: 5+4 in 11 of 14 cores) who was referred for initial staging with 99m Tc-HYNIC-PSMA. The scan was reported as miT 2m N 2(REI, ROB) M 1b(uni) M 1c(skin?) , PRIMARY score: 4, PSMA expression score: 1-3. We incidentally discovered increased uptake in the left skull region on whole-body images. Subsequent SPECT/CT imaging localized this uptake to a subcutaneous nodule in the scalp, which pathologic analysis confirmed to be a neurofibroma. Several lesions of neurological origin may exhibit significant PSMA avidity, which is reviewed here.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (3)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반